Frontal Fibrosing Alopecia Clinical Trial
Official title:
Follicular Revival in Fibrosing Alopecia: Evaluating Use of Micro-needling
To evaluate the efficacy microneedling via a professional tattoo machine in revitalizing hair follicles in patients with fibrosing alopecia.
The investigators propose an open label trial of tattoo machine microneedling in ten patients with fibrosing alopecia (five patients with CCCA and five with FFA). Ten healthy female patients older than 18 years will undergo 6 microneedling sessions. Over the course of six months, subjects will undergo up to six treatment sessions (one session every 30 day). Photographs will be taken at each session. Patients will be evaluated at 8 visits over 8 months with the first visit for screening purposes. Each visit will last about an hour. Approximately 30 minutes will be spent on consenting and time for patient to ask questions during the first visit. The remaining 30 minutes will be allotted for the investigator to determine if the patient meets criteria for trial enrollment. During the remaining visits, 20 minutes will be allotted for photography, 15-20 minutes for the procedure and 10-15 minutes for post-procedure patient assessment. Remaining 10 minutes on visits 2 and 8 will be used for biopsy. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04409041 -
Oral Low-Dose Naltrexone for Lichen Planopilaris and Frontal Fibrosing Alopecia
|
Phase 2 | |
| Completed |
NCT03630198 -
Pain Outcomes Following Intralesional Corticosteroid Injections
|
Phase 4 | |
| Enrolling by invitation |
NCT06202560 -
Effectiveness and Safety of Tofacitinib in Patients With Recalcitrant Frontal Fibrosing Alopecia : A Pilot Study
|
N/A | |
| Not yet recruiting |
NCT03335228 -
Platelet Rich Plasma for Frontal Fibrosing Alopecia
|
N/A | |
| Not yet recruiting |
NCT02467101 -
Study to Assess the Efficacy of Intralesional Corticosteroid on the Treatment of Frontal Fibrosing Alopecia
|
N/A | |
| Recruiting |
NCT03422640 -
Trial Evaluating the Efficacy of Apremilast for the Treatment of Frontal Fibrosing Alopecia
|
Phase 4 | |
| Completed |
NCT03346668 -
Role of Neurogenic Inflammation and Topical 6% Gabapentin Therapy in Symptomatic Scarring Alopecia
|
Early Phase 1 | |
| Active, not recruiting |
NCT03082560 -
Design and Validation of a New Assessment Tool for Lichen Planopilaris
|
||
| Recruiting |
NCT06240351 -
A Study to Evaluate the Safety and Efficacy of Baricitinib in the Treatment of Frontal Fibrosing Alopecia (FFA)
|
Phase 4 | |
| Completed |
NCT05332366 -
A Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Adults With Frontal Fibrosing Alopecia
|
Phase 2 |